홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

카바놀에이트

Carbanolate

HCID 522251
새 반응
인쇄

데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다

기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
671-04-5
표준 SMILES
CNC(=O)Oc1cc(C)c(C)cc1Cl
InChIKey
QRTXZGIQTYDABO-UHFFFAOYSA-N
분자식
C10H12ClNO2
평균 분자량
213.66 g/mol
단동위원소 질량
213.0556563

개요

Carbanolate is a carbamate ester that is phenyl methylcarbamate which is substituted by a chloro group at position 2 and by methyl groups at positions 4 and 5, respectively. It is an insecticide used in the the control of poultry ectoparasites. It has a role as an acaricide, a carbamate insecticide and an EC 3.1.1.7 (acetylcholinesterase) inhibitor. It is a carbamate ester and a member of monochlorobenzenes.

이름 및 식별자

우선 이름
Carbanolate
IUPAC
(2-chloro-4,5-dimethylphenyl) N-methylcarbamate
현지명
카바놀에이트
영어명
Banol
분자식
C10H12ClNO2
분자량
213.66

이름 및 동의어

CARBANOLATE671-04-5ChloroxylamBanol Tuco SokOMS-1742-Chloro-4,5-dimethylphenyl methylcarbamateUpjohn U-12,9272-Chloro-4,5-xylyl N-methylcarbamate3,4-Dimethyl-6-chlorophenyl N-methylcarbamate6-Chloro-3,4-dimethylphenyl N-methylcarbamate6-Chloro-3,4-xylyl N-methylcarbamatePhenol, 2-chloro-4,5-dimethyl-, methylcarbamate
이름 더 보기
카바놀레이트카바놀에이트(2-클로로-3,4-다이메틸페닐) N-메틸카바메이트2-클로로-4,5-다이메틸페놀, 1-(N-메틸카바메이트)2-클로로-4,5-다이메틸페놀, 메틸카바메이트2-클로로-4,5-다이메틸페닐 메틸카바메이트3,4-다이메틸-6-클로로페닐 N-메틸카바메이트3,4-자일릴-6-클로로-N-메틸카바메이트6-클로로-3,4-다이메틸페닐 N-메틸카바메이트6-클로로-3,4-자일릴 메틸카바메이트메틸카밤산, 6-클로로-3,4-자일릴 에스터바놀TemixBanolu12927sok[qr]Banol-D3aldicard
M05Z0Q9XTF2-Chloro-4,5-dimethylphenyl N-methylcarbamate6-Chloro-3,4-xylenyl N-methylcarbamateU 12927U-17004Carbamic acid, methyl-, 6-chloro-3,4-xylyl esterCarbamic acid, methyl-, 2-chloro-4,5-xylyl ester2-Chloro-4,5-dimethylphenol methylcarbamate

물성

구조 계산 물성보충 중

XLogP
2.7
극성 표면적
38.3 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
2
회전 가능 결합 수
2
무거운 원자 수
14
형식 전하
0
복잡도
210

실험 및 물리화학적 성질

PesticidesPesticides -> Carbamate Insecticides
LogP2.3
Color/FormCRYSTALLINE SOLID
Solubility · 2건

FREELY SOL IN CHLOROFORM, SLIGHTLY SOL IN WATER

SOLUBILITY: ACETONE 25%, BENZENE 14%, TOLUENE 10%, XYLENE 6.7%, KEROSENE LESS THAN 2%

CorrosivityNON-CORROSIVE
Melting Point · 2건

130-133 °C

MP: 122.5-124.5 °C /TECHNICAL PRODUCT/

Vapor Pressure0.000922 [mmHg]
Physical DescriptionSolid; [HSDB]
Stability/Shelf Life · 2건

UNSTABLE @ TEMP ABOVE MELTING POINT

DECOMP IN ALKALI

물리화학적 성질

녹는점
130 · 130-133 °C

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 3건

Danger

H300: Fatal if swallowed [Danger Acute toxicity, oral]

P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)

유해성 정보

Hazards SummaryInhibited cholinesterase activity in animal feeding studies; [HSDB] See CARBAMATE INSECTICIDES.
Hazard Classes and CategoriesAcute toxicity (Oral) - Category 2

안전 및 보호

Exposure Control and Personal Protection · 1건

Biological Exposure Indices (BEI) [ACGIH] - Acetylcholinesterase activity in red blood cells = 70% of individual's baseline; Butylcholinesterase activity in serum or plasma = 60% of individual's baseline; Sample at end of shift; [TLVs and BEIs]

독성 정보

Treatment · 2건

If the compound has been ingested, rapid gastric lavage should be performed using 5% sodium bicarbonate. For skin contact, the skin should be washed with soap and water. If the compound has entered the eyes, they should be washed with large quantities of isotonic saline or water. In serious cases, atropine and/or pralidoxime should be administered. Anti-cholinergic drugs work to counteract the effects of excess acetylcholine and reactivate AChE. Atropine can be used as an antidote in conjunction with pralidoxime or other pyridinium oximes (such as trimedoxime or obidoxime), though the use of '-oximes' has been found to be of no benefit, or possibly harmful, in at least two meta-analyses. Atropine is a muscarinic antagonist, and thus blocks the action of acetylcholine peripherally.

화학 및 산업

약리 정보

Metabolism/Metabolites · 6건

FOLLOWING SUBACUTE ORAL ADMIN OF BANOL TO RATS, ELIMINATION WAS...COMPLETE WITHIN 48 HR. METHYLAMINE TO CARBON DIOXIDE WERE IDENTIFIED AS METABOLITES. A NUMBER OF OTHER METABOLITES INCL GLUCURONATES WERE OBSERVED BUT NOT IDENTIFIED. IN MORE RECENT STUDIES, 2-CHLORO-4,5-XYLYL N-HYDROXYMETHYLCARBAMATE AND 2-CHLORO-4,5-XYLENOL WERE IDENTIFIED AFTER INCUBATION OF BANOL IN RAT LIVER MICROSOME-NADPH2 SYSTEM. ... DEGRADATION OF BANOL BY MICROSOMES OR BY WHOLE BLABERUS GIGANTEUS FAT BODY RESULTED IN FORMATION OF AT LEAST 3 METABOLITES. ONE OF THESE WAS N-HYDROXYMETHYL BANOL.

NATURE OF METABOLITES OF BANOL STUDIES USING (14)C-LABEL AT CARBONYL, 4-METHYL, & N-METHYL GROUPINGS. THE LIVER PREPN WERE ABOUT EQUAL IN THEIR RATES OF BIOTRANSFORMATION... CARBOXYLIC ACIDS...TOGETHER WITH SMALL AMT OF CORRESPONDING PHENOLIC ACIDS (3-4%), FORMED BY SUBSEQUENT ESTERATIC CLEAVAGE, WERE THE MAJOR ETHER-SOL PRODUCTS (8-14%). ONLY RAT LIVER YIELDED THE N-HYDROXYMETHYLCARBAMATE (6%).

BANOL YIELDS 2-CHLORO-4,5-DIMETHYLPHENOL & 2-CHLORO-4,5-DIMETHYLPHENYL HYDROXYMETHYLCARBAMATE IN MAN & IN RAT. STROTHER A; TOXICOL APPL PHARMAC 21: 112 (1972). OONNITHAN ES & CASIDA JE; J AGRIC FD CHEM 16: 28 (1968). 2-CHLORO-4,5-DIMETHYLPHENYL HYDROXYMETHYLCARBAMATE ALSO IN BEANS. KUHR RJ & CASIDA JE; J AGRIC FD CHEM 15: 814 (1967). /FROM TABLE/

THERE IS NO EVIDENCE TO SUGGEST THAT MONOALKYLCARBAMATES SUCH AS...CARBANOLATE ARE DEALKYLATED DIRECTLY; RATHER, THEY ARE ATTACKED BY N-METHYLHYDROXYLATION & SUBSEQUENTLY CONJUGATED.

For more Metabolism/Metabolites (Complete) data for CARBANOLATE (6 total), please visit the HSDB record page.

The carbamates are hydrolyzed enzymatically by the liver; degradation products are excreted by the kidneys and the liver. (L793)

용도 및 제조

Uses · 5건

Used as acaricide and insecticide; [HSDB]

Farming (Pesticides) [Category: Industry]

ACARICIDE, INSECTICIDE

6-Chloro-3,4-xylyl methylcarbamate is widely used as an insecticide or pesticide in homes, gardens and agricultural applications. It is a synthetic compound.

Carbanolate is widely used as an insecticide or pesticide in homes, gardens and agricultural applications. It is a synthetic compound.

관련 반응

0건
반응 기록 만들기
아직 관련 반응이 없습니다

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트

데이터베이스 식별자

CAS
671-04-5、68989-02-6
PubChem CID
522251
DTXSID
DTXSID7041754
ChEBI
CHEBI:82090
UNII
M05Z0Q9XTF
Nikkaji
J2.104K
끓는 점
306.8 · 306.8±42.0 °C(Predicted)
밀도
1.2069 · 1.2069 (rough estimate)
굴절률
1.55 · 1.5500 (estimate)
산도 계수 (pKa)
11.83 · 11.83±0.46(Predicted)
EPA
Carbanolate (671-04-5)

If the compound has been ingested, rapid gastric lavage should be performed using 5% sodium bicarbonate. For skin contact, the skin should be washed with soap and water. If the compound has entered the eyes, they should be washed with large quantities of isotonic saline or water. In serious cases, atropine and/or pralidoxime should be administered. Anti-cholinergic drugs work to counteract the effects of excess acetylcholine and reactivate AChE. Atropine can be used as an antidote in conjunction with pralidoxime or other pyridinium oximes (such as trimedoxime or obidoxime), though the use of '-oximes' has been found to be of no benefit, or possibly harmful, in at least two meta-analyses. Atropine is a muscarinic antagonist, and thus blocks the action of acetylcholine peripherally.

Health Effects · 2건

Acute exposure to cholinesterase inhibitors can cause a cholinergic crisis characterized by severe nausea/vomiting, salivation, sweating, bradycardia, hypotension, collapse, and convulsions. Increasing muscle weakness is a possibility and may result in death if respiratory muscles are involved. Accumulation of ACh at motor nerves causes overstimulation of nicotinic expression at the neuromuscular junction. When this occurs symptoms such as muscle weakness, fatigue, muscle cramps, fasciculation, and paralysis can be seen. When there is an accumulation of ACh at autonomic ganglia this causes overstimulation of nicotinic expression in the sympathetic system. Symptoms associated with this are hypertension, and hypoglycemia. Overstimulation of nicotinic acetylcholine receptors in the central nervous system, due to accumulation of ACh, results in anxiety, headache, convulsions, ataxia, depression of respiration and circulation, tremor, general weakness, and potentially coma. When there is expression of muscarinic overstimulation due to excess acetylcholine at muscarinic acetylcholine receptors symptoms of visual disturbances, tightness in chest, wheezing due to bronchoconstriction, increased bronchial secretions, increased salivation, lacrimation, sweating, peristalsis, and urination can occur. Chronically high (>10 years) exposure leads to neuropsychological consequences including disturbances in perception and visuo-motor processing (A15321).

Acute exposure to cholinesterase inhibitors can cause a cholinergic crisis characterized by severe nausea/vomiting, salivation, sweating, bradycardia, hypotension, collapse, and convulsions. Increasing muscle weakness is a possibility and may result in death if respiratory muscles are involved. Accumulation of ACh at motor nerves causes overstimulation of nicotinic expression at the neuromuscular junction. When this occurs symptoms such as muscle weakness, fatigue, muscle cramps, fasciculation, and paralysis can be seen. When there is an accumulation of ACh at autonomic ganglia this causes overstimulation of nicotinic expression in the sympathetic system. Symptoms associated with this are hypertension, and hypoglycemia. Overstimulation of nicotinic acetylcholine receptors in the central nervous system, due to accumulation of ACh, results in anxiety, headache, convulsions, ataxia, depression of respiration and circulation, tremor, general weakness, and potentially coma. When there is expression of muscarinic overstimulation due to excess acetylcholine at muscarinic acetylcholine receptors symptoms of visual disturbances, tightness in chest, wheezing due to bronchoconstriction, increased bronchial secretions, increased salivation, lacrimation, sweating, peristalsis, and urination can occur. Chronically high (>10 years) exposure leads to neuropsychological consequences including disturbances in perception and visuo-motor processing (A15321).

Adverse EffectsOther Poison - Carbamate
Exposure Routes · 2건

Inhalation (L793) ; oral (L793); dermal (L793)

Inhalation (L793) ; oral (L793); dermal (L793)

Toxicity Summary · 2건

6-Chloro-3,4-xylyl methylcarbamate is a cholinesterase or acetylcholinesterase (AChE) inhibitor. Carbamates form unstable complexes with chlolinesterases by carbamoylation of the active sites of the enzymes. This inhibition is reversible. A cholinesterase inhibitor suppresses the action of acetylcholine esterase. Because of its essential function, chemicals that interfere with the action of acetylcholine esterase are potent neurotoxins, causing excessive salivation and eye-watering in low doses. Headache, salivation, nausea, vomiting, abdominal pain and diarrhea are often prominent at higher levels of exposure. Acetylcholine esterase breaks down the neurotransmitter acetylcholine, which is released at nerve and muscle junctions, in order to allow the muscle or organ to relax. The result of acetylcholine esterase inhibition is that acetylcholine builds up and continues to act so that any nerve impulses are continually transmitted and muscle contractions do not stop.

Carbanolate is a cholinesterase or acetylcholinesterase (AChE) inhibitor. Carbamates form unstable complexes with chlolinesterases by carbamoylation of the active sites of the enzymes. This inhibition is reversible. A cholinesterase inhibitor suppresses the action of acetylcholine esterase. Because of its essential function, chemicals that interfere with the action of acetylcholine esterase are potent neurotoxins, causing excessive salivation and eye-watering in low doses. Headache, salivation, nausea, vomiting, abdominal pain and diarrhea are often prominent at higher levels of exposure. Acetylcholine esterase breaks down the neurotransmitter acetylcholine, which is released at nerve and muscle junctions, in order to allow the muscle or organ to relax. The result of acetylcholine esterase inhibition is that acetylcholine builds up and continues to act so that any nerve impulses are continually transmitted and muscle contractions do not stop.

Signs and Symptoms · 2건

As with organophosphates, the signs and symptoms are based on excessive cholinergic stimulation. Unlike organophosphate poisoning, carbamate poisonings tend to be of shorter duration because the inhibition of nervous tissue acetylcholinesterase is reversible, and carbamates are more rapidly metabolized. Muscle weakness, dizziness, sweating and slight body discomfort are commonly reported early symptoms. Headache, salivation, nausea, vomiting, abdominal pain and diarrhea are often prominent at higher levels of exposure. Contraction of the pupils with blurred vision, incoordination, muscle twitching and slurred speech have been reported. (L795)

As with organophosphates, the signs and symptoms are based on excessive cholinergic stimulation. Unlike organophosphate poisoning, carbamate poisonings tend to be of shorter duration because the inhibition of nervous tissue acetylcholinesterase is reversible, and carbamates are more rapidly metabolized. Muscle weakness, dizziness, sweating and slight body discomfort are commonly reported early symptoms. Headache, salivation, nausea, vomiting, abdominal pain and diarrhea are often prominent at higher levels of exposure. Contraction of the pupils with blurred vision, incoordination, muscle twitching and slurred speech have been reported. (L795)

Human Toxicity Excerpts · 1건

See carbaryl. Symptomatology: 1. Nausea, vomiting, abdominal cramps, diarrhea & excessive salivation...sweating. 2. Lassitude & weakness. 3. Rhinorrhea and sensation of tightness in chest may occur with inhalation exposure. 4. Blurring or dimness of vision. Miosis...tearing, ciliary muscle spasm, loss of accommodation and ocular pain. None of these...signs...is dependable for diagnosis. Mydriasis may be seen... 5. Loss of muscle coordination, slurring of speech, fasciculation & twitching of muscles. 6. Difficulty in breathing, excessive secretions of saliva and of resp tract mucus, oronasal frothing, cyanosis, pulmonary rales & rhonchi, and hypertension. 7. ...jerky movements, incontinence, convulsions and coma. 8. Death...due to resp arrest of central origin, paralysis of resp muscles, intense bronchoconstriction or all three. /Carbaryl/

Carcinogen Classification · 2건

No indication of carcinogenicity to humans (not listed by IARC).

No indication of carcinogenicity to humans (not listed by IARC).

Non-Human Toxicity Excerpts · 3건

INSECTICIDAL CARBAMATES ARE HIGHLY CHOLINERGIC, & POISONED INSECTS & OTHER ANIMALS EXHIBIT VIOLENT CONVULSIONS & OTHER NEUROMUSCULAR DISTURBANCES. /CARBAMATE INSECTICIDES/

...PERMANENT BEHAVIORAL ABERRATIONS /WERE DOCUMENTED/ IN RATS WHICH RECEIVED CARBARYL OR PROPOXUR REPEATEDLY, ALTHOUGH THE AUTHORS DID NOT CONSIDER EITHER CARBAMATE TO BE A DANGEROUS NEUROTOXIN. /CARBARYL/

Very high acute oral toxicity in laboratory animals. Cholinesterase inhibitor.

Antidote and Emergency Treatment · 5건

1) ESTABLISH CLEAR AIRWAY & TISSUE OXYGENATION BY ASPIRATION OF SECRETIONS & IF NECESSARY, BY ASSISTED PULMONARY VENTILATION WITH OXYGEN. IMPROVE TISSUE OXYGENATION AS MUCH AS POSSIBLE BEFORE ADMINISTERING ATROPINE TO MINIMIZE THE RISK OF VENTRICULAR FIBRILLATION. /CARBAMATES, CHOLINESTERASE INHIBITORS/

2) ADMIN ATROPINE SULFATE IV, OR IM IF IV INJECTION IS NOT POSSIBLE... IN MODERATELY SEVERE POISONING: ADULT DOSAGE, INCLUDING CHILDREN OVER 12 YR: 0.4-2.0 MG REPEATED EVERY 15 MIN UNTIL ATROPINIZATION IS ACHIEVED (TACHYCARDIA, FLUSHING, DRY MOUTH, MYDRIASIS). MAINTAIN ATROPINIZATION BY REPEATED DOSES FOR 2-12 HR, OR LONGER, DEPENDING ON SEVERITY OF POISONING... DOSAGE FOR CHILDREN UNDER 12 YEARS: 0.05 MG/KG BODY WT REPEATED EVERY 15 MIN UNTIL ATROPINIZATION IS ACHIEVED. MAINTAIN ATROPINIZATION WITH REPEATED DOSAGE OF 0.02-0.05 MG/KG. SEVERELY POISONED INDIVIDUALS MAY EXHIBIT REMARKABLE TOLERANCE TO ATROPINE; TWICE THE DOSES SUGGESTED ABOVE MAY BE NEEDED... /CARBAMATES, CHOLINESTERASE INHIBITORS/

3. PRALIDOXIME (PROTOPAM-AYERST, 2-PAM) IS OF DOUBTFUL VALUE IN POISONINGS BY CARBAMATE INHIBITORS OF CHOLINESTERASE. ATROPINE ALONE IS ALMOST ALWAYS AN ADEQUATE ANTIDOTE. PRALIDOXIME IS PROBABLY CONTRAINDICATED IN POISONINGS BY CARBARYL, SPECIFICALLY. IF VICTIM OF CARBAMATE POISONING EXHIBITS SEVERE MUSCLE WEAKNESS &/OR RESPIRATORY DEPRESSION, OR IF POISONING INVOLVES A COMBINATION OF CARBAMATE & ORGANOPHOSPHATE, A DILUTE SOLUTION OF PRALIDOXIME (TOTAL DOSE IN 250 ML 5% GLUCOSE SOLN) MAY BE GIVEN CAUTIOUSLY IV. THE INFUSION SHOULD BE TERMINATED IF PATIENT'S CONDITION WORSENS. PRALIDOXIME DOSAGE: ADULTS, 1.0 G; FOR CHILDREN UNDER 12 YR, 20-50 MG/KG. 4. OBSERVE TREATED PATIENTS CLOSELY AT LEAST 24 HR TO INSURE THAT SYMPTOMS (POSSIBLY PULMONARY EDEMA) DO NOT RECUR AS ATROPINIZATION WEARS OFF. IN VERY SEVERE POISONINGS, METABOLIC DISPOSITION OF TOXICANT MAY REQUIRE SEVERAL HR OR DAYS DURING WHICH ATROPINIZATION MUST BE MAINTAINED. /CARBAMATES, CHOLINESTERASE INHIBITORS/

5. BATHE & SHAMPOO VICTIM WITH SOAP & WATER IF THERE IS ANY CHANCE THAT SKIN & HAIR ARE CONTAMINATED. 6. IF PESTICIDE HAS BEEN INGESTED IN QUANTITY SUFFICIENT TO CAUSE POISONING, EMPTY THE STOMACH & INTESTINE. A. IF VICTIM IS ALERT & RESPIRATION IS NOT DEPRESSED, GIVE SYRUP OF IPECAC, FOLLOWED BY 1-2 GLASSES OF WATER TO INDUCE VOMITING; ADULTS (INCLUDING CHILDREN OVER 12), 30 ML; CHILDREN (UNDER 12 YR), 15 ML. CAUTION: OBSERVE VICTIM CLOSELY AFTER ADMIN IPECAC, IF CONSCIOUSNESS LEVEL DECLINES, OR IF VOMITING HAS NOT OCCURRED IN 15 MIN, PROCEED IMMEDIATELY TO INTUBATE THE STOMACH. FOLLOWING EMESIS, HAVE VICTIM DRINK A SUSPENSION OF /PRC: 30 G ACTIVATED CHARCOAL IN 3-4 OZ OF WATER (CHILDREN), 100 G IN 8-10 OZ OF WATER (ADULTS)/...TO BIND TOXICANT REMAINING IN THE GI TRACT. /CARBAMATES, CHOLINESTERASE INHIBITORS/

For more Antidote and Emergency Treatment (Complete) data for CARBANOLATE (6 total), please visit the HSDB record page.

안전 데이터

ridadr
2757
포장분류
II
위험 등급
6.1(a)
기존화학 물질
KE-05-0986
유해 물질 데이터
671-04-5(Hazardous Substances Data)
함량 및 규제정보
물질구분: 유독물질; 혼합물(제품)함량정보: 카바놀에이트 및 이를 1% 이상 함유한 혼합물
유해화학물질 필터링
97-1-251
Formulations/PreparationsWETTABLE POWDER 75% AI, FOR USE IN CONCENTRATE OR DIL SPRAYS. DUST--VARIABLE CONCN PREPD UPON REQUEST.
General Manufacturing Information · 2건

SHOULD NOT BE USED WITH LIME OR OTHER ALKALINE MATERIALS. .../USED/ IN CONTROL OF INSECTS OF PLANTS & ANIMALS. HAS GOOD RESIDUAL PROPERTIES & EXCELLENT PLANT TOLERANCE. EXCELLENT CONTROL OF CHINCH BUG, COCKROACH, ETC. INTRODUCED AS ACARICIDE.

Discontinued product of The Upjohn Company.

응용 분야

용도2-Chloro-4,5-dimethylphenyl methylcarbamate is a pesticide.

상·하류 제품 정보

하류 제품

알디카브